Literature DB >> 2158637

Enormous dystrophin in a patient with Becker muscular dystrophy.

C Angelini1, A H Beggs, E P Hoffman, M Fanin, L M Kunkel.   

Abstract

We describe a patient with a duplication of more than 400,000 bp of the dystrophin gene. The duplication is completely contained within the gene, and the duplicated exons are predicted to be "in frame" with the rest of the gene. Dystrophin protein is detected in the patient's muscle as a single species of approximately 600 kDa (normal, approximately 400 kDa), indicating that the resulting mutated gene codes for a translatable mRNA of over 100 exons (normal, approximately 70 exons). The patient's mother carries the duplicated gene as determined by both DNA and protein analysis. The described duplication of the dystrophin gene is by far the largest characterized to date. This observation is of significant biologic interest in that, despite the gross alteration of the gene and the encoded protein, the patient has a relatively mild clinical progression compatible with a diagnosis of Becker muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2158637     DOI: 10.1212/wnl.40.5.808

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  The effects of glucocorticoid therapy on the inflammatory and dendritic cells in muscular dystrophies.

Authors:  Mahmoud R Hussein; Sherifa A Hamed; Mohammed G Mostafa; Eman E Abu-Dief; Nageh Fouly Kamel; Mahmoud R Kandil
Journal:  Int J Exp Pathol       Date:  2006-12       Impact factor: 1.925

2.  A model to estimate the expression of the dystrophin gene in muscle from female Becker muscular dystrophy carriers.

Authors:  M Vainzof; M R Passos-Bueno; R C Pavanello; R Schreiber; M Zatz
Journal:  J Med Genet       Date:  1992-07       Impact factor: 6.318

3.  A 400-kb tandem duplication within the dystrophin gene leads to severe Becker muscular dystrophy.

Authors:  R Gold; W Kress; T Bettecken; H Reichmann; C R Müller
Journal:  J Neurol       Date:  1994-03       Impact factor: 4.849

4.  Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies.

Authors:  A H Beggs; E P Hoffman; J R Snyder; K Arahata; L Specht; F Shapiro; C Angelini; H Sugita; L M Kunkel
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

5.  Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathies.

Authors:  Luca Bello; Paola Campadello; Andrea Barp; Marina Fanin; Claudio Semplicini; Gianni Sorarù; Luca Caumo; Chiara Calore; Corrado Angelini; Elena Pegoraro
Journal:  Sci Rep       Date:  2016-09-01       Impact factor: 4.379

Review 6.  Current and emerging therapies in Becker muscular dystrophy (BMD).

Authors:  Corrado Angelini; Roberta Marozzo; Valentina Pegoraro
Journal:  Acta Myol       Date:  2019-09-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.